Background: Uncontrolled hemorrhage from vessel injuries within the torso remains a significant source of prehospital trauma mortality. Resuscitative endovascular balloon occlusion of the aorta can effectively control non-compressible hemorrhage, but this minimally invasive technique relies heavily upon imaging not available in the field. Our goal was to develop morphometric roadmaps to enhance the safety and accuracy of fluoroscopy-free endovascular navigation of hemorrhage control devices. Methods: Three-dimensional reconstructions of computed tomography angiography scans from n=122 trauma patients (mean age 47+/-24 years, range 5-93 years, 64 Male/58 Female) were used to measure centerline distances from femoral artery access sites to the major aortic branch artery origins. Morphometric roadmap equations were created using multiple linear regression analysis to predict distances to the origins of the major arteries in the chest, abdomen and pelvis using torso length, demographics, and risk factors as independent variables. A 40-mm long occlusion balloon was then virtually deployed targeting Zones 1 and 3 of the aorta using these equations. Balloon placement accuracy was determined by comparing predicted versus actual measured distances to the target zone locations within the aortas from the database. Results: Torso length and age were the strongest predictors of centerline distances from femoral artery access sites to the major artery origins. Male gender contributed to longer distances while diabetes and smoking were associated with shorter distances. Hypertension, dyslipidemia and coronary artery disease had no effect. Using morphometric roadmaps, virtual occlusion balloon placement accuracy was 100% for Zone 3 of the aorta, compared to 87% accuracy when using torso length alone. Conclusion: Morphometric roadmaps demonstrate potential for improving the safety and accuracy of fluoroscopy-free aortic occlusion balloon delivery. Continued development of minimally invasive hemorrhage control techniques hold promise to improve prehospital mortality for patients with noncompressible exsanguinating torso injuries. Level of evidence: Diagnostic, level III. (C) 2016 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1oclf1x
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Heart from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2nvshyG
-
Abstract Introduction Access to timely, quality, and affordable surgical services is an important component of health care systems. A be...
-
Abstract Background Data about the influence of pregnancy on progression-free survival and overall survival of glioma patients are spars...
-
Safe Life Defense is at SHOT SHOW 2018! Be the FIRST IN THE WORLD to win the New Tactical Vest! from EMS via xlomafota13 on Inoreader http...
-
Download this podcast on iTunes , SoundCloud or via RSS feed Our co-hosts sit down with EMS1 Editor-in-Chief Greg Friese to discuss this ...
-
http://bit.ly/2DG5b3i
-
The REACT-2 trial is an RCT comparing two different diagnostic strategies in a cohort of patients presenting to the Emergency Department wi...
-
Objective: Blunt trauma patients may present with similar demographics and injury severity yet differ with regard to survival. We hypothesi...
-
Objectives: To compare physicians’ perceptions and practice of end-of-life care in the ICU in three East Asian countries cultures similarly ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου